Technologietransfer News
Toggle filters
Park Innovaare: Financing of new Campus is secured
After an intensive round of negotiations, Park Innovaare concluded an investment agreement with CPV/CAP Pensionskasse Coop for the realization of the new buildings. With this agreement, Park Innovaare has come another step closer to realizing its goal: a state-of-the-art infrastructure of about 38’000 sqm next to the Paul Scherrer Institute PSI that is ideal for industrial R&D projects.
Congratulations to Debiopharm
Debiopharm – a Swiss pharma company that has licensed-in one of PSIs developments -a compound with high potential for cancer diagnosis & therapy has been nominated for the “2019/2020 Swiss Biotech Sucess Stories Awards”